China approves use of Pfizer's COVID-19 drug Paxlovid

BEIJING - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the country. The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said. It is not immediately clear if China is already in talks with Pfizer to procure the pill. "This is an important milestone in our fight against COVID-19," a Pfizer representative said in a statement, without providing information about procurement. The approval is a boost to Pfizer which expects $22 billion in 2022 sales of the treatment. Pfizer executives have said the company is in active discussions with over 100 countries about Paxlovid, and has the capacity to provide 120 million courses if needed. While a number of vaccines are available worldwide to help prevent infection and serious illness, including one made by Pfizer, there are limited treatment options for people infected with COVID-19. Pfizer in December said final trial results showed its treatment reduced the chance of hospitalisation or death by 89% in COVID-19 patients at risk of severe illness given the treatment within three days of the onset of symptoms, and by 88% when given within five days of onset. The United States is paying around $530 for each course of Paxlovid and $700 for each course of rival COVID-19 pill molnupiravir developed by Merck & Co. China has kept daily number of new COVID-19 patients with confirmed symptoms to below 250, and sometimes fewer than 10, in the past year. The number is small for its 1.4 billion population and by global standards, thanks to China's approach of quickly containing any local flare-ups as soon as possible and its weeks-long quarantine requirement for most travellers arriving from abroad. China has yet to approve any COVID-19 vaccines developed by foreign drugmakers but has vaccinated 87.1% of its entire population by Feb. 7 using several domestically developed shots. (Reporting by Roxanne Liu and John Horwitz; Editing by Miyoung Kim and Lincoln Feast.) ((william.mallard@thomsonreuters.com; +81 3 4563 2749;))

China approves use of Pfizer's COVID-19 drug Paxlovid

DISCOVER MORE

5.3 magnitude earthquake strikes Turkish province

Dubai World Cup: Simon hopes Algiers can emulate the great Dubai Millennium

30 recipes in 30 days: Dubai shares original dishes for Ramadan

Cricket World Cup: Who's in, who could be out

Messi scores in Artgetina's homecoming celebration

UAE weather: Temperatures to dip to 7ºC, partly cloudy day ahead

Civil Defense issues warning as weather fluctuations expected in most Saudi regions

Billionaire brings luxury dinner-show concept to Doha

GCC central banks track US Fed move; hike key rates by 25bps

VIDEO: LSE-listing will facilitate more funding opportunities for us, Dar Global CEO

Dubai's Meraas to build new residential towers in Design District

Abu Dhabi's Mubadala, Ares set up $1bln JV to invest in credit secondaries

Egypt to get $7bln in funding as World Bank approves new development framework

Xi tells Hong Kong's leaders to control COVID-19 as infections spiral

China pledges support for Hong Kong as infections set to hit new record

China's Xi meets four more heads of state in Olympic diplomacy push

Taiwan condemns 'contemptible' timing of China-Russia partnership

China suspected in hack of journalists at News Corp

LATEST VIDEO

VIDEO: LSE-listing will facilitate more funding opportunities for us, Dar Global CEO

ZAWYA COVERAGE

Dubai's Emirates expands training fleet with $4.3mln aircraft order

2 African development banks invest $16bln in oil, gas projects

Global trade set to stagnate in H1 2023 after hitting a record $32trln last year

UK’s Bank of England raises interest rates again to 4.25%

Dining with lions, underwater experience: 9 unique Iftars to try this Ramadan

5.3 magnitude earthquake strikes Turkish province

Dubai World Cup: Simon hopes Algiers can emulate the great Dubai Millennium

30 recipes in 30 days: Dubai shares original dishes for Ramadan

Pilot travelling as passenger helps land plane as captain faints on US flight

THE BRI REPORT

China is reshaping the Belt and Road Initiative ahead of a post-pandemic era

DISCOVER MORE

LATEST VIDEO

ZAWYA NEWSLETTERS

ZAWYA COVERAGE